ArticlePLoS medicine2006
Nonhuman primate models for SARS.
Article in PLoS medicine, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control.Signal transduction and targeted therapy · 2024Review
- Implications of testicular ACE2 and the renin-angiotensin system for SARS-CoV-2 on testis function.Nature reviews. Urology · 2022Review
- A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model.Frontiers in immunology · 2022Article
- A Blueprint for High Affinity SARS-CoV-2 Mpro Inhibitors from Activity-Based Compound Library Screening Guided by Analysis of Protein Dynamics.ACS pharmacology & translational science · 2021Article
- Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic research.Human vaccines & immunotherapeutics · 2020Review
- The Coronaviruses of Animals and Birds: Their Zoonosis, Vaccines, and Models for SARS-CoV and SARS-CoV2.Frontiers in veterinary science · 2020Review
- Molecular pathology of emerging coronavirus infections.The Journal of pathology · 2015Review
- Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques.Proceedings of the National Academy of Sciences of the United States of America · 2013Article
- Development of a rhesus monkey lung geometry model and application to particle deposition in comparison to humans.Inhalation toxicology · 2012Article
- Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species.Journal of virology · 2011Article
- Exacerbated innate host response to SARS-CoV in aged non-human primates.PLoS pathogens · 2010Article
- The SARS-CoV ferret model in an infection-challenge study.Virology · 2008Article
- Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium.Journal of virology · 2008Article
- Are nonhuman primates good models for SARS?PLoS medicine · 2006Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.